{"filing":{"accession_number":"0001645113-26-000065","cik":"0001645113","ticker":"NVCR","company_name":"NovoCure Ltd","form":"8-K","filing_date":"2026-09-01","report_date":"2026-09-01","primary_document":"nvcr-20260901.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1645113/000164511326000065/nvcr-20260901.htm"},"events":[{"id":30765,"run_id":28204,"accession_number":"0001645113-26-000065","anchor_item_number":"8.01","event_type":"cybersecurity_incident","event_domain":"legal","is_material":true,"confidence":0.95,"summary":"NovoCure disclosed unauthorized access to its information systems in mid-August 2026 affecting over 1,400 U.S. patient records with internal patient ID numbers and fewer than 50 additional patient records with identifying information, plus healthcare provider and employee contact data. Although the Company states it does not currently believe the incident will have material financial impact, the disclosure of a cybersecurity breach involving patient data is itself material to investors under Item 1.05 (required since 2023) and affects the total mix of information available regarding operational risk, regulatory compliance, and potential liability exposure.","company_name":"NovoCure Ltd","ticker":"NVCR","filing_date":"2026-09-01","form":"8-K","submitted_at":null,"items":[{"id":33471,"accession_number":"0001645113-26-000065","item_number":"8.01","item_title":"Other Events.","event_type":"cybersecurity_incident","event_domain":"legal","is_material":true,"confidence":0.95,"reasoning":"NovoCure disclosed unauthorized access to its information systems in mid-August 2026 affecting over 1,400 U.S. patient records with internal patient ID numbers and fewer than 50 additional patient records with identifying information, plus healthcare provider and employee contact data. Although the Company states it does not currently believe the incident will have material financial impact, the disclosure of a cybersecurity breach involving patient data is itself material to investors under Item 1.05 (required since 2023) and affects the total mix of information available regarding operational risk, regulatory compliance, and potential liability exposure.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-01T11:01:56.971636+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":33471,"accession_number":"0001645113-26-000065","item_number":"8.01","item_title":"Other Events.","event_type":"cybersecurity_incident","event_domain":"legal","is_material":true,"confidence":0.95,"reasoning":"NovoCure disclosed unauthorized access to its information systems in mid-August 2026 affecting over 1,400 U.S. patient records with internal patient ID numbers and fewer than 50 additional patient records with identifying information, plus healthcare provider and employee contact data. Although the Company states it does not currently believe the incident will have material financial impact, the disclosure of a cybersecurity breach involving patient data is itself material to investors under Item 1.05 (required since 2023) and affects the total mix of information available regarding operational risk, regulatory compliance, and potential liability exposure.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-01T11:01:56.971636+00:00","company_name":"NovoCure Ltd","ticker":"NVCR","filing_date":"2026-09-01"}]}